In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Esperion Therapeutics Inc (NASDAQ: ESPR) closed at $1.17 in the last session, down -5.65% from day before closing price of $1.24. In other words, the price has decreased by -$5.65 from its previous closing price. On the day, 2.93 million shares were traded. ESPR stock price reached its highest trading level at $1.27 during the session, while it also had its lowest trading level at $1.145.
Ratios:
We take a closer look at ESPR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.81 and its Current Ratio is at 1.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 17 ’25 when Looker Benjamin sold 1,304 shares for $1.13 per share. The transaction valued at 1,470 led to the insider holds 399,937 shares of the business.
Halladay Benjamin sold 11 shares of ESPR for $12 on Jul 17 ’25. The Chief Financial Officer now owns 474,462 shares after completing the transaction at $1.11 per share. On Jul 17 ’25, another insider, Looker Benjamin, who serves as the Officer of the company, bought 1,304 shares for $1.13 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 231892832 and an Enterprise Value of 674477568. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.89. Its current Enterprise Value per Revenue stands at 2.598 whereas that against EBITDA is -16.898.
Stock Price History:
The Beta on a monthly basis for ESPR is 0.80, which has changed by -0.5145228 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is 14.34%, while the 200-Day Moving Average is calculated to be -30.91%.
Shares Statistics:
According to the various share statistics, ESPR traded on average about 4.50M shares per day over the past 3-months and 2955700 shares per day over the past 10 days. A total of 196.66M shares are outstanding, with a floating share count of 194.63M. Insiders hold about 1.80% of the company’s shares, while institutions hold 57.47% stake in the company. Shares short for ESPR as of 1749772800 were 24113664 with a Short Ratio of 5.34, compared to 1747267200 on 27945316. Therefore, it implies a Short% of Shares Outstanding of 24113664 and a Short% of Float of 12.2200005.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
